IMS Health has proceeded with its IPO, raising $1.3bn, and shares have risen by 15 percent on its trading debut.The timing of the move was announced two weeks ago and the IPO was first hinted at in January. The eventual share price of $20 is towards the upper end of the range suggested and valued the company at around $6.64bn - shares are now trading at $23.
IMS was taken private in March 2010 by investment firms TPG Capital and the Canada Pension Plan Investment Board (CPPIB), who paid $5.2bn. The pharma intelligence giant apparently intends to use most of the proceeds to repay debt.
Web site: www.imshealth.com .
All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.
Register (free) for Daily Research News
REGISTER FOR NEWS EMAILS
To receive (free) news headlines by email, please register online